标题
Pharmacokinetic and pharmacodynamic evaluation of tigecycline
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 7, Issue 11, Pages 1459-1470
出版商
Informa Healthcare
发表日期
2011-10-01
DOI
10.1517/17425255.2011.623126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase
- (2011) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia
- (2010) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
- (2010) May Nguyen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia
- (2010) C. Pichardo et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Superinfection during treatment of nosocomial infections with tigecycline
- (2010) E. García-Cabrera et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Multidrug-resistant Gram-negative bacteria: how to treat and for how long
- (2010) Helen Giamarellou INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics and Safety of a Single Intravenous Dose of the Antibiotic Tigecycline in Patients With Cirrhosis
- (2010) Joan M. Korth-Bradley et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacodynamic Profile of Tigecycline against Methicillin-Resistant Staphylococcus aureus in an Experimental Pneumonia Model
- (2009) P. Koomanachai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates
- (2009) A. M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic issues for antibiotics in the critically ill patient
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Application of patient population-derived pharmacokinetic–pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci
- (2009) Paul G. Ambrose et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Multidrug-Resistant Gram-Negative Infections
- (2009) Helen Giamarellou et al. DRUGS
- Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
- (2009) Olaf Burkhardt et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii
- (2009) Jun-Chang Cui et al. JOURNAL OF ANTIBIOTICS
- Breakthrough bacteraemia with a susceptible Enterococcus faecalis during tigecycline monotherapy
- (2009) M. Parsonage et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline
- (2009) N. C. Gordon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs
- (2009) J. L. Crandon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
- (2009) Garyphallia Poulakou et al. JOURNAL OF INFECTION
- In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
- (2009) Luigi Principe et al. Annals of Clinical Microbiology and Antimicrobials
- In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy
- (2008) E. S. Moland et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pandrug Resistance (PDR), Extensive Drug Resistance (XDR), and Multidrug Resistance (MDR) among Gram‐Negative Bacilli: Need for International Harmonization in Terminology
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: Results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007
- (2008) Michael J. Dowzicky et al. CLINICAL THERAPEUTICS
- Use of a clinically derived exposure–response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints
- (2008) Paul G. Ambrose et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST)
- (2008) Sam K. Bouchillon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A sensitive human bone assay for quantitation of tigecycline using LC/MS/MS
- (2008) Allena J. Ji et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Pharmacodynamic Performance of Tigecycline versus Common Intravenous Antibiotics for the Empiric Treatment of Complicated Skin and Skin Structure Infections
- (2008) Joseph L. Kuti et al. Surgical Infections
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started